These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32885627)

  • 41. [Antithrombotic therapy in chronic coronary syndromes--value of thrombocyte aggregation inhibition, anticoagulation and chronic thrombolysis].
    Leschke M; Schoebel FC; Stiegler H; Fischer Y; Schannwell CM; Strauer BE
    Z Kardiol; 1998; 87 Suppl 2():145-51. PubMed ID: 9827473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic therapy after myocardial infarction.
    Becker RC
    N Engl J Med; 2002 Sep; 347(13):1019-22. PubMed ID: 12324559
    [No Abstract]   [Full Text] [Related]  

  • 43. Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2014; 129(1):55-64. PubMed ID: 25116427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombotic therapy in acute coronary syndromes.
    Watson RD; Chin BS; Lip GY
    BMJ; 2002 Dec; 325(7376):1348-51. PubMed ID: 12468488
    [No Abstract]   [Full Text] [Related]  

  • 45. Coronary artery dissection and left ventricular thrombus.
    Drury-Smith M; Horton R; Khogali S
    Postgrad Med J; 2012 Sep; 88(1043):553-4. PubMed ID: 22647667
    [No Abstract]   [Full Text] [Related]  

  • 46. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
    Cardiac Society of Australia and New Zealand
    Heart Lung Circ; 2010 Jan; 19(1):2-10. PubMed ID: 20045378
    [No Abstract]   [Full Text] [Related]  

  • 47. Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis.
    Yao SK; Ober JC; Ferguson JJ; Maffrand JP; Anderson HV; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1993; 106():110-9. PubMed ID: 8036734
    [No Abstract]   [Full Text] [Related]  

  • 48. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
    O'Brien M; Parness IA; Neufeld EJ; Baker AL; Sundel RP; Newburger JW
    Pediatrics; 2000 May; 105(5):E64. PubMed ID: 10799628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
    Levin M; Burns JC; Gordon JB
    Cardiology; 2014; 129(3):174-7. PubMed ID: 25300244
    [No Abstract]   [Full Text] [Related]  

  • 51. Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
    Loomba RS
    Cardiology; 2015; 130(3):164-5. PubMed ID: 25676566
    [No Abstract]   [Full Text] [Related]  

  • 52. Simultaneous subacute sirolimus-eluting stent thrombosis in multi-vessel coronary artery at discharge.
    Yu M; Hu J; Chen X; Zhang B; Qin Y; Zhao X
    Int J Cardiol; 2013 Sep; 168(2):e76-8. PubMed ID: 23890902
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet and anticoagulant drugs in coronary vascular disease.
    FitzGerald GA; Shipp E
    Ann Epidemiol; 1992 Jul; 2(4):529-42. PubMed ID: 1342304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optical coherence tomography findings during "evolving" stent thrombosis.
    Zakhem B; Fernandez-Ortiz A; Alfonso F
    J Invasive Cardiol; 2011 Sep; 23(9):E222-5. PubMed ID: 21891818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough?
    Molina-Martin de Nicolas J; Jurado Roman A; Rubio Alonso B; Garcia Tejada J
    JACC Cardiovasc Interv; 2015 Apr; 8(4):e55-7. PubMed ID: 25819181
    [No Abstract]   [Full Text] [Related]  

  • 58. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
    Granitskiĭ NA
    Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
    [No Abstract]   [Full Text] [Related]  

  • 59. Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?
    Jiménez-Quevedo P; Angiolillo DJ; Bernardo E; Sabaté M
    Catheter Cardiovasc Interv; 2004 May; 62(1):39-42. PubMed ID: 15103601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.